Uzun süreli azathiopürin tedavisi sonrası görülen erüptif melanositik nevüs olgusu

Year 2016, Volume: 2 Issue: 3, 208 - 210, 01.09.2016

Zehide Eriş Eken Banu Taşkın İlker Yazıcı Başak Namdar Çelikkan Ömer Çay İpek Çoban Fatmagül Kuşku Çabuk Sibel Alper

Abstract

Bu yazıda, otoimmün hepatit tanısı ile çocukluk döneminde aralıklı olarak immünsüpresif tedavi görmüş erüptif melanositik nevüsleri olan 27 yaşında, bir kadın hasta sunuldu.

Keywords

Dermoskopi, erüptif melanositik nevüs, immunsüpresif tedavi, melanom

References

• Belloni Fortina A, Piaserico S, Zattra E, Alaibac M. Dermoscopic features of eruptive melanocytic naevi in an adult patient receiving immunosuppressive therapy for Crohn’s disease. Melanoma Res 2005;15:223-4.
• Smalley KS. Understanding melanoma signaling networks as the basis for molecular targeted therapy. J Invest Dermatol 2010;130:28-37.
• Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature 2007;445:851-7.
• Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, et al. High frequency of BRAF mutations in nevi. Nat Genet 2003;33:19-20.
• Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, et al. BRAFE600- associated senescence-like cell cycle arrest of human naevi. Nature 2005;436:720-4.
• Gray-Schopfer VC, Cheong SC, Chong H, Chow J, Moss T, Abdel-Malek ZA, et al. Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer 2006;95:496-505.
• Maldonado JL, Timmerman L, Fridlyand J, Bastian BC. Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway. Am J Pathol 2004;164:1783-7.
• Sekulic A, Colgan MB, Davis MD, DiCaudo DJ, Pittelkow MR. Activating BRAF mutations in eruptive melanocytic naevi. Br J Dermatol 2010;163:1095-8.
• John JK, Smalley KS. Identification of BRAF mutations in eruptive melanocytic nevi: new insights into melanomagenesis? Expert Rev Anticancer Ther 2011;11:711-4.